The Effect of Coconut Oil on Alopecia
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Coconut Oil.
- Who it may be relevant to
- Registry conditions: Breast Cancer. Basic parameters: 18 years — 65 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
The Effect of Coconut Oil on Alopecia in Women Receiving Doxorubucin-Cycylophosphamide Treatment for Breast Cancer
Overview
İn this study will be conducted to evaluate the effect of coconut oil on alopecia in 86 female breast cancer patients treated at Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital between 01.02.2025-31.12.2025.
Detailed description
Cancer is a disease in which the cells in our body multiply uncontrollably and develop by metastasizing, and the symptoms, course and consequences of the disease can show complex qualities in each patient. Cancer treatments have benefits and harms. One of these side effects is alopecia.
Alopecia due to cancer treatments is a condition of hair loss, partial or complete, usually temporary but rarely permanent.
In chemotherapy-induced alopecia, the hair follicle is damaged due to the pause in the anagen phase and causes the hair to break off spontaneously during activities such as washing and brushing the hair.
Various scales are used in the evaluation of alopecia due to cancer treatments, such as the National Cancer Institute Common Terminology Criteria for Side Effects and the Dean Alopecia Scale.
Some applications are made to prevent and treat alopecia. These include strategies and pharmacological applications to physically reduce the amount of medication given to the hair follicle.
Coconut oil helps regrow damaged hair. It provides essential proteins necessary for hair and softens the scalp and hair.
In the literature, it has been observed that studies showing the effects of coconut oil for the prevention and treatment of alopecia are insufficient. This study will be conducted on 86 breast cancer patients to determine the effect of coconut oil on the development of alopecia.
Interventions
- Other Coconut Oil
The coconut oil application protocol will be explained to the patients in the experimental group and 10 milliliters of coconut oil will be applied to the hair follicles once a week. Alopecia assessment will be done every week.
Primary outcome measures
- National Cancer Instute (NCI) Common Terminology Criteria for Adverse Events (CTCAE); Alopecia [Time frame: 1-12 WEEK]
Eligibility criteria
Inclusion criteria
- • To have been diagnosed with breast cancer.
- The chemotherapy treatment plan should be planned as the Doxorubicin-Cyclophosphamide protocol.
- Volunteer to participate in the study.
- Be 18 years of age or older.
- Being a woman.
Exclusion criteria
- • Having any health problem or disability that prevents communication (vision-hearing problems, neurological, psychiatric diseases).
- Planning other treatments other than the Doxorubicin-Cyclophosphamide protocol for the treatment of breast cancer.
- Not volunteering to participate in the study.
- Having previously experienced any disease/skin problem that causes hair loss.
- Having received chemotherapy before.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Supportive care
Study locations
Turkey (Türkiye) · 1 center
- Dr. Abdurrahman Yurtaslan Ankara Onkoloji Eğitim ve Araştırma Hastanesi — Ankara
Identifiers
NCT: NCT06818370 · Ankara Onkoloji EAH